Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer

Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer

Background: Recent studies showed a relevant role of hematogenous spread in ovarian cancer and the interest of circulating tumor cells (CTCs) monitoring as a prognosis marker. The aim of the present study was the characterization of CTCs from ovarian cancer patients, paying special attention to cell...

Full description

Bibliographic Details
Main Authors:	Manuel Abreu, Pablo Cabezas-Sainz, Lorena Alonso-Alconada, Alba Ferreirós, Patricia Mondelo-Macía, Ramón Manuel Lago-Lestón, Alicia Abalo, Eva Díaz, Sara Palacios-Zambrano, Alejandro Rojo-Sebastian, Rafael López-López, Laura Sánchez, Gema Moreno-Bueno, Laura Muinelo-Romay
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Series:	Cells
Subjects:	ovarian cancer circulating tumor cells (CTCs) cell plasticity TIMP1
Online Access:	https://www.mdpi.com/2073-4409/9/5/1218

Similar Items

Analysis of a Real-World Cohort of Metastatic Breast Cancer Patients Shows Circulating Tumor Cell Clusters (CTC-clusters) as Predictors of Patient Outcomes
by: Clotilde Costa, et al.
Published: (2020-04-01)

Biosensors for the Detection of Circulating Tumour Cells
by: Clotilde Costa, et al.
Published: (2014-03-01)

TIMP1 and TIMP2 Downregulate TGFβ Induced Decidual-like Phenotype in Natural Killer Cells
by: Adriana Albini, et al.
Published: (2021-10-01)

TIMP way to stop metastasis?
by: Katarzyna Jarosz, et al.
Published: (2017-08-01)

TIMP way to stop metastasis?
by: Katarzyna Jarosz, et al.
Published: (2017-08-01)

Global Gene Expression Characterization of Circulating Tumor Cells in Metastasic Castration-Resistant Prostate Cancer Patients
by: Luis León-Mateos, et al.
Published: (2020-07-01)

Changes in Gene and Protein Expression of Metalloproteinase-2 and -9 and Their Inhibitors TIMP2 and TIMP3 in Different Parts of Fluoride-Exposed Rat Brain
by: Agnieszka Łukomska, et al.
Published: (2020-12-01)

TIMP3 overexpression in myeloid lineage alleviates pancreatic damage and confers resistance to the development of type 1 diabetes in the MLDS -induced model
by: Viviana Casagrande, et al.
Published: (2024-01-01)

TIMP2 promotes intramuscular fat deposition by regulating the extracellular matrix in chicken
by: Huan-xian CUI, et al.
Published: (2023-03-01)

Effect of simvastatin on MMPs and TIMPs in cigarette smoke-induced rat COPD model
by: Sun J, et al.
Published: (2017-02-01)

Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis—Case Series Report
by: Arleta Waszczykowska, et al.
Published: (2020-11-01)

Higher levels of circulating TIMP-4 in preeclampsia is strongly associated with clinical parameters and microRNA
by: Valéria C. Sandrim, et al.
Published: (2018-10-01)

Changes in the expression and methylation levels of the MMP-2, MMP-9, TIMP-1, TIMP-2 and VEGF-A genes in children with acute lymphoblastic leukemia
by: Atila Tanyel,i, et al.
Published: (2021-06-01)

Tissue inhibitors of metalloproteinases (TIMPs) modulate platelet ADAM10 activity
by: Christine Shu Mei Lee, et al.
Published: (2023-12-01)

Anti-POSTN and Anti-TIMP1 Autoantibodies as Diagnostic Markers in Esophageal Squamous Cell Carcinoma
by: Weihong Xie, et al.
Published: (2022-04-01)

Expression of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors (TIMPs) in Frozen Sperm of Rabbit
by: Sang Hwan Kim, et al.
Published: (2019-09-01)

The Predictive Role of MMP-2, MMP-9, TIMP-1 and TIMP-2 Serum Levels in the Complete Response of the Tumor to Chemotherapy in Breast Cancer Patients
by: Kayhan Ozdemir, et al.
Published: (2022-07-01)

Immunohistochemical characteristics of MMP-9 and TIMP-1 markers expression in the cerebral cortex in diabetes mellitus type 2
by: V. O. Shavrin, et al.
Published: (2020-08-01)

The Role of TIMP-2 Gene in Skin Cancer
by: Negar Zoghaghi, et al.
Published: (2017-02-01)

TIMP1 is an early biomarker for detection and prognosis of lung cancer
by: Ezequiel Dantas, et al.
Published: (2023-10-01)

Detection and dynamics of circulating tumor cells in patients with high-risk prostate cancer treated with radiotherapy and hormones: a prospective phase II study
by: Almudena Zapatero, et al.
Published: (2020-06-01)

Expression of matrix metalloproteinases (MMP-1, MMP-2 and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in oral submucous fibrosis
by: Rajendran R, et al.
Published: (2006-01-01)

Regulatory T cells provide chondroprotection through increased TIMP1, IL-10 and IL-4, but cannot mitigate the catabolic effects of IL-1β and IL-6 in a tri-culture model of osteoarthritis
by: Laura E. Keller, et al.
Published: (2021-09-01)

Plasma Extracellular Vesicle-Derived TIMP-1 mRNA as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma: A Pilot Study
by: Francisca Dias, et al.
Published: (2020-06-01)

TIMP3 promotes the maintenance of neural stem-progenitor cells in the mouse subventricular zone
by: Lingyan Fang, et al.
Published: (2023-06-01)

Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients
by: Patricia Mondelo-Macía, et al.
Published: (2020-02-01)

Effect of Cordyceps sinensis on TIMP-1 secretion from mouse melanoma cell
by: Kubo Erika, et al.
Published: (2012-02-01)

Altered TIMP-3 Levels in the Cerebrospinal Fluid and Plasma of Patients with Alzheimer’s Disease
by: Jung Hyun Park, et al.
Published: (2022-05-01)

Whole organism profiling of the Timp gene family
by: David Peeney, et al.
Published: (2023-06-01)

The invariant chain CD74 protein is a cell surface binding partner of TIMP‐1 in breast cancer cells
by: Mikkel Høeberg, et al.
Published: (2023-08-01)

Down-regulation of miR-4443/TIMP2 signaling pathway enhances sorafenib sensitivity in HepG2 cells
by: XIAO Hanxi, et al.
Published: (2021-02-01)

Transcriptomic landscape of TIMP3 oncosuppressor activity in thyroid carcinoma
by: M. Mazzoni, et al.
Published: (2022-12-01)

Comparing TIMP-1 and Hsp70 in Blood and Saliva as Potential Prognostic Markers in HNSCC
by: Jakob Rinecker, et al.
Published: (2022-12-01)

Epigenomic reprogramming of therapy-resistant circulating tumor cells in colon cancer
by: Aida Bao-Caamano, et al.
Published: (2023-12-01)

Effect of TGFβ1 and TIMP2 on Disease Activity in Asthma and COPD
by: Mostafa Ghanei, et al.
Published: (2010-06-01)

TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells
by: Ruth M. Escalona, et al.
Published: (2020-10-01)

Circulating matrix metalloproteinase MMP-9 and MMP-2/TIMP-2 complex are associated with spontaneous early pregnancy failure
by: Nissi Ritva, et al.
Published: (2013-01-01)

TIMP1 Indicates Poor Prognosis of Renal Cell Carcinoma and Accelerates Tumorigenesis via EMT Signaling Pathway
by: Yi Shou, et al.
Published: (2022-02-01)

Berberine prevents primary peritoneal adhesion and adhesion reformation by directly inhibiting TIMP-1
by: Xin Liu, et al.
Published: (2020-05-01)

Chemerin deficiency regulates adipogenesis is depot different through TIMP1
by: Cheng-Long Huang, et al.
Published: (2021-09-01)